Bank Of New York Mellon Corp Invitae Corp Transaction History

Bank Of New York Mellon Corp

$521 Trillion
Q1 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$1.2 - $2.73 $1.02 Million - $2.33 Million	853,859 New	853,859 $1.15 Billion
Q4 2022 Feb 14, 2023	BUY	$1.71 - $3.61 $1.48 Million - $3.12 Million	864,798 New	864,798 $1.61 Million
Q3 2022 Nov 14, 2022	BUY	$1.9 - $8.63 $261,740 - $1.19 Million	137,758 Added 18.75%	872,657 $2.15 Million
Q2 2022 Aug 15, 2022	SELL	$2.13 - $9.01 $371,107 - $1.57 Million	-174,229 Reduced 19.16%	734,899 $1.79 Million
Q1 2022 May 11, 2022	SELL	$6.28 - $15.59 $71,598 - $177,741	-11,401 Reduced 1.24%	909,128 $7.25 Million

Q4 2021 Feb 11, 2022	SELL	$14.7 - $28.67 $22,564 - $44,008	-1,535 Reduced 0.17%	920,529 $14.1 Million
Q3 2021 Nov 12, 2021	BUY	$24.31 - $33.6 $1.57 Million - $2.17 Million	64,731 Added 7.55%	922,064 $26.2 Million
Q2 2021 Aug 11, 2021	BUY	$26.09 - $40.4 $7.66 Million - $11.9 Million	293,725 Added 52.12%	857,333 $28.9 Million
Q1 2021 May 13, 2021	BUY	$33.06 - $56.93 $39,605 - $68,202	1,198 Added 0.21%	563,608 $21.5 Million
Q4 2020 Feb 09, 2021	SELL	$39.09 - $57.4 $22.8 Million - $33.5 Million	-583,535 Reduced 50.92%	562,410 $23.5 Million
Q3 2020 Nov 12, 2020	SELL	$28.43 - $44.67 $10.5 Million - $16.4 Million	-367,802 Reduced 24.3%	1,145,945 $49.7 Million
Q2 2020 Aug 12, 2020	BUY	$11.71 - $30.29 $1.29 Million - $3.33 Million	110,059 Added 7.84%	1,513,747 $45.9 Million
Q1 2020 May 06, 2020	BUY	$7.64 - $27.5 $7.67 Million - $27.6 Million	1,004,572 Added 251.7%	1,403,688 $19.2 Million
Q4 2019 Feb 14, 2020	SELL	$15.02 - $20.57 $18,234 - $24,971	-1,214 Reduced 0.3%	399,116 $6.44 Million
Q3 2019 Nov 07, 2019	BUY	$18.85 - $27.5 $595,678 - $869,027	31,601 Added 8.57%	400,330 $7.71 Million
Q2 2019 Aug 12, 2019	BUY	$17.37 - $26.27 $37,588 - $56,848	2,164 Added 0.59%	368,729 $8.67 Million
Q1 2019 May 14, 2019	BUY	$10.65 - $25.75 $835,396 - $2.02 Million	78,441 Added 27.22%	366,565 $8.59 Million
Q4 2018 Feb 11, 2019	SELL	$9.26 - $16.38 $49,466 - $87,501	-5,342 Reduced 1.82%	288,124 $3.19 Million
Q3 2018 Nov 09, 2018	BUY	$7.54 - $18.31 $252,130 - $612,268	33,439 Added 12.86%	293,466 $0
Q2 2018 Aug 06, 2018	BUY	$4.87 - $8.42 $259,108 - $447,986	53,205 Added 25.73%	260,027 $1.91 Million
Q1 2018 May 15, 2018	BUY	$4.69 - $10.05 $35,751 - $76,611	7,623 Added 3.83%	206,822 $970,000
Q4 2017 Feb 09, 2018	BUY	$7.86 - $9.99 $1.57 Million - $1.99 Million	199,199	199,199 $1.81 Million

Others Institutions Holding NVTA

# of Institutions

Shares Held

7.66M

Call Options Held

Put Options Held

View Full List

About Invitae Corp

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

More about NVTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account